WX [WuXi PharmaTech (Cayman)] F-3: (Original Filing)

[] [[MAPLES AND CALDER LETTERHEAD] Our ref AEO\628564\3415033v2 Direct +852 2971 3081 Email alice.ooi@maplesandcalder.com Wuxi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People Republic of China 4 September 2009 Dear Sir Wuxi PharmaTech (Cayman) Inc. Company Registration Statement Commission Act Prospectus ADSs Shares Unissued Shares We act as Cayman Islands counsel for Wuxi PharmaTech (Cayman)] [September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131, PRC Re: American Depositary Shares Representing Ordinary Shares of WuXi PharmaTech (Cayman) Inc. Ladies and Gentlemen: September 4, 2009 - Page 2 The above opinion is provided to the Company for the Company’s use in connection with the transactions that are the subject] [Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel: (8610) 65693399 Fax: (8610) 65693838, 65693836, 65693837, 65693839 www.tongshang.com.cn E-mail Add: beijing@tongshang.com Website: September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People’s Republic of China Dear Sirs: For the purposes of giving this] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated June 25, 2009, relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness of WuXi PharmaTech (Cayman) Inc.’s internal control over financial reporting, appearing in the Annual Report]

By | 2016-04-02T20:40:10+00:00 September 4th, 2009|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

CPHI [CHINA PHARMAS,] 8-K: ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS;

[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]

By | 2016-02-08T00:17:34+00:00 September 4th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] F-3:

[] [[MAPLES AND CALDER LETTERHEAD] Our ref AEO\628564\3415033v2 Direct +852 2971 3081 Email alice.ooi@maplesandcalder.com Wuxi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People Republic of China 4 September 2009 Dear Sir Wuxi PharmaTech (Cayman) Inc. Company Registration Statement Commission Act Prospectus ADSs Shares Unissued Shares We act as Cayman Islands counsel for Wuxi PharmaTech (Cayman)] [September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131, PRC Re: American Depositary Shares Representing Ordinary Shares of WuXi PharmaTech (Cayman) Inc. Ladies and Gentlemen: September 4, 2009 - Page 2 The above opinion is provided to the Company for the Company’s use in connection with the transactions that are the subject] [Commerce & Finance Law Offices 6F NCI Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing, PRC; Postcode: 100022 Tel: (8610) 65693399 Fax: (8610) 65693838, 65693836, 65693837, 65693839 www.tongshang.com.cn E-mail Add: beijing@tongshang.com Website: September 4, 2009 WuXi PharmaTech (Cayman) Inc. 288 Fute Zhong Road Waigaoqiao Free Trade Zone Shanghai 200131 People’s Republic of China Dear Sirs: For the purposes of giving this] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated June 25, 2009, relating to the financial statements and financial statement schedule of WuXi PharmaTech (Cayman) Inc., and the effectiveness of WuXi PharmaTech (Cayman) Inc.’s internal control over financial reporting, appearing in the Annual Report]

By | 2016-04-02T20:41:06+00:00 September 4th, 2009|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More

ATAI [ATA] 6-K: (Original Filing)

[Contact: ATA Inc. CCG Investor Relations Phone: +(1) 646-213-1914 ATA Announces Results for First Fiscal Quarter 2010 BEIJING, September 3, 2009 — ATA Inc. (“ATA” or the “Company”) (NASDAQ: ATAI), the leading provider of computer-based testing and testing-related services in China, today announced its unaudited financial results for its first quarter ended June 30, 2009 (“First Quarter 2010”). First Quarter] [Form 6-K September 3, 2009 ATA Inc. ——————————————————————————————————— 8th Floor, Tower E ——————————————————————————————————— x x n/a ATA Inc. Carl Yeung Carl Yeung Chief Financial Officer Description 99.1 Press Release dated September 3, 2009 6-K 1 htm_4254.htm LIVE FILING]

By | 2016-04-03T13:16:55+00:00 September 4th, 2009|Categories: ATAI, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

SGOC [SGOCO] 6-K: (Original Filing)

[Entry into Letter of Intent for Business Combination The consummation of the business combination is subject to, among other things, execution of a definitive agreement and required stockholder approval. There can be no assurance that a business combination will be consummated. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation]

By | 2016-03-13T18:09:48+00:00 September 4th, 2009|Categories: Chinese Stocks, SEC Original, SGOC|Tags: , , , , , |0 Comments
Read More

SGOC [SGOCO] 6-K: Entry into Letter of Intent for Business Combination

[Entry into Letter of Intent for Business Combination The consummation of the business combination is subject to, among other things, execution of a definitive agreement and required stockholder approval. There can be no assurance that a business combination will be consummated. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation]

By | 2016-03-13T18:10:49+00:00 September 4th, 2009|Categories: Chinese Stocks, SGOC, Webplus ver|Tags: , , , , , |0 Comments
Read More

SIMO [Silicon Motion Technology] SC 13G: (Original Filing)

[1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Coatue Management, L.L.C. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6.]

By | 2016-03-14T21:00:39+00:00 September 4th, 2009|Categories: Chinese Stocks, SEC Original, SIMO|Tags: , , , , , |0 Comments
Read More

SIMO [Silicon Motion Technology] SC 13G: 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS.

[1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Coatue Management, L.L.C. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6.]

By | 2016-03-14T21:01:42+00:00 September 4th, 2009|Categories: Chinese Stocks, SIMO, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar